The disease-modifying antirheumatic drug leflunomide does not substantially increase the risk for adverse pregnancy outcomes when taken inadvertently, researchers reported January 28th in an online paper in Arthritis & Rheumatism. Reuters Health Information (Source: Medscape Medical News Headlines)

Further information:

Article source

Related posts:

1. Uric Acid Level, Alcohol, Other Factors Increase Risk of Gout in Women
2. Uterine Contractions in Labor Improve Neonatal Respiratory Outcomes
3. Mayo Clinic Determines Lifetime Risk of Adult Rheumatoid Arthritis
4. Ondansetron Ineffective for Chronic Fatigue Syndrome
5. Medical and Surgical Treatments for Obesity Have Different Effects on Appetite